scispace - formally typeset
Search or ask a question
Institution

Central Drug Research Institute

FacilityLucknow, Uttar Pradesh, India
About: Central Drug Research Institute is a facility organization based out in Lucknow, Uttar Pradesh, India. It is known for research contribution in the topics: Leishmania donovani & Brugia malayi. The organization has 4357 authors who have published 7257 publications receiving 143871 citations. The organization is also known as: Central Drug Research Institute, Lucknow & CDRI.


Papers
More filters
Journal ArticleDOI
TL;DR: First synthesis of novel coumarin-trioxane hybrids is reported and the novel hybrids were evaluated for their antimalarial activity both in vitro and in vivo.

50 citations

Journal ArticleDOI
TL;DR: In this paper, a one-step facile synthesis of aromatic, heteroaromatic, allylic and aliphatic nitriles from primary alcohols catalyzed by ferric nitrate [Fe(NO3)3⋅9H2O] in the presence of TEMPO, aqueous ammonia and air at room temperature is described.
Abstract: A highly practical, one-step, facile synthesis of aromatic, heteroaromatic, allylic and aliphatic nitriles from primary alcohols catalyzed by ferric nitrate [Fe(NO3)3⋅9H2O] in the presence of TEMPO, aqueous ammonia and air at room temperature is described.

50 citations

Journal ArticleDOI
TL;DR: An efficient NaNO2 /I2 -mediated one-pot transformation of Morita-Baylis-Hillman (MBH) acetates into alkyl 3-nitro-5-(aryl/alkyl)isoxazole-4-carboxylates is described and structural elaborations by SN Ar reactions and hydrogenolysis allows access to useful products.
Abstract: An efficient NaNO2 /I2 -mediated one-pot transformation of Morita-Baylis-Hillman (MBH) acetates into alkyl 3-nitro-5-(aryl/alkyl)isoxazole-4-carboxylates is described. In a cascade event, initial Michael addition of NaNO2 to the MBH acetate furnishes the allylnitro intermediate which undergoes I2 -catalyzed oxidative α-CH nitration of the nitromethyl subunit followed by [3+2] cycloaddition to afford the title compounds. Structural elaborations of these highly substituted isoxazoles by SN Ar reactions and hydrogenolysis allows access to useful products.

50 citations

Journal ArticleDOI
TL;DR: An asymmetric, organocatalytic, one-pot Mannich cyclization between a hydroxylactam and acetal is described to provide fused, bicyclic alkaloids bearing a bridgehead N’atom.
Abstract: An asymmetric, organocatalytic, one-pot Mannich cyclization between a hydroxylactam and acetal is described to provide fused, bicyclic alkaloids bearing a bridgehead N atom. Both aliphatic and aromatic substrates were used in this transformation to furnish chiral pyrrolizidinone, indolizidi- none, and quinolizidinone derivatives in up to 89 % yield and 97 % ee. The total syntheses of (� )-epilupinine, (� )-tashir- omine, and (� )-trachelanthamidine also achieved to demon- strate the generality of the process. Naturally occurring izidine alkaloids (pyrrolizidine, indoli- zidine, and quinolizidine; Figure 1 A) and their synthetic variants are of considerable importance because of their diverse biological activities. (1) While the polyhydroxylated izidines inhibit glycosidase and glycosyl-transfer enzymes, and show anti-HIV, anti-dengue virus, anticancer, anti- inflammatory, and antidiabetic activities, (2) the alkylated

50 citations

Journal ArticleDOI
TL;DR: Among 80 compounds screened, six compounds showed in vitro activity against Mycobacterium tuberculosis (MABA) at a concentration of 50 and 25 microg/mL.

50 citations


Authors

Showing all 4385 results

NameH-indexPapersCitations
Sanjay Kumar120205282620
John A. Katzenellenbogen9569136132
Brajesh K. Singh8340124101
Gaurav Sharma82124431482
Sudhir Kumar82524216349
Pramod K. Srivastava7939027330
Mohan K. Raizada7547321452
Syed F. Ali7144618669
Ravi Shankar6667219326
Ramesh Chandra6662016293
Manoj Kumar6540816838
Manish Kumar61142521762
Anil Kumar Saxena5831010107
Sanjay Krishna5662413731
Naibedya Chattopadhyay562429795
Network Information
Related Institutions (5)
Merck & Co.
48K papers, 1.9M citations

93% related

GlaxoSmithKline
21.1K papers, 1.1M citations

92% related

Bristol-Myers Squibb
21K papers, 932.5K citations

92% related

Novartis
50.5K papers, 1.9M citations

91% related

Pfizer
37.4K papers, 1.6M citations

91% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20233
202255
2021306
2020232
2019246
2018289